ICL trades 25.1% below Wall Street's consensus target of $6.43.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ICL achieves its forward estimates and maintains a stable P/E multiple of 12.3x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, ICL Group Ltd (ICL) has a Wall Street consensus price target of $6.43, based on estimates from 4 covering analysts. With the stock currently trading at $5.14, this represents a potential upside of +25.1%. The company has a market capitalization of $6.63B.
Analyst price targets range from a low of $5.80 to a high of $7.00, representing a 19% spread in expectations. The median target of $6.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, ICL trades at a trailing P/E of 28.6x and forward P/E of 12.3x. The forward PEG ratio of 0.21 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +107.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $10.58, with bear and bull scenarios of $6.67 and $13.95 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MOSThe Mosaic Company | $7.3B | $22.90 | $28.00 | +22.3% | Hold | 27.8x | 49 |
NTRNutrien Ltd. | $30.2B | $62.86 | $82.00 | +30.4% | Buy | 11.0x | 33 |
CFCF Industries Holdings, Inc. | $15.8B | $102.93 | $111.88 | +8.7% | Buy | 6.0x | 41 |
SMGThe Scotts Miracle-Gro Company | $3.8B | $64.69 | $72.25 | +11.7% | Buy | 14.9x | 17 |
IPIIntrepid Potash, Inc. | $463M | $34.49 | $26.00 | -24.6% | Hold | 27.6x | 26 |
AVDAmerican Vanguard Corporation | $76M | $2.65 | $17.00 | +541.5% | Buy | 7.0x | 13 |
FMCFMC Corporation | $1.4B | $11.55 | $16.10 | +39.4% | Hold | 6.8x | 42 |
ASXASE Technology Holding Co., Ltd. | $88.7B | $40.56 | — | — | Buy | 1.2x | 5 |
DEDeere & Company | $159.1B | $589.24 | $690.00 | +17.1% | Hold | 32.6x | 46 |
CTVACorteva, Inc. | $52.7B | $78.56 | $89.13 | +13.5% | Buy | 21.0x | 37 |
Quick answers to the most common questions about buying ICL stock.
The consensus Wall Street price target for ICL is $6.43, representing 25.1% upside from the current price of $5.14. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ICL has a consensus rating of "Hold" based on 4 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $6.43 implies 25.1% upside from current levels.
With a forward P/E of 12.2732x, ICL trades at a relatively low valuation. The consensus target of $6.43 implies 25.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $7 for ICL, while the most conservative target is $5.8. The consensus of $6.43 represents the median expectation. Our quantitative valuation model projects a bull case target of $14 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ICL is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ICL stock forecast based on 4 Wall Street analysts shows a consensus price target of $6.43, with estimates ranging from $5.8 (bear case) to $7 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $11, with bear/bull scenarios of $7/$14.
Our quantitative valuation model calculates ICL's fair value at $11 (base case), with a bear case of $7 and bull case of $14. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.
ICL trades at a forward P/E ratio of 12.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 28.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ICL, with a "Hold" consensus rating and $6.43 price target (25.1% upside). 0 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ICL analyst price targets range from $5.8 to $7, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $6.43 consensus represents the middle ground. Our model's $7-$14 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.